The aforementioned experiments in genetically engineered mice demonstrated that the endogenous AM-RAMP2 system ameliorates uveitis pathogenesis in the EAU model by suppressing T-cell and macrophage infiltration into the retina and reducing proinflammatory cytokine expression in the retina. This evidence concerns the gene RAMP2 and uveitis.